Sign In
Sign Up
Two Blokes
SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease
click to rate
Posted by
Two Blokes
May 26
- Filed in
Stock
- 2 views
SWTX wins CHMP backing for mirdametinib in NF1-PN. EU nod is expected in the third quarter of 2025.